TPI1 and TPM4 are strong candidate RNA biomarkers for systemic sclerosis
Open Access
- 4 February 2026
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 28 (1)
Abstract
Systemic Sclerosis (SSc) is an autoimmune rheumatic disease (ARD) with unclear aetiopathogenesis. Disease prognosis, diagnosis, and treatment are challengiKeywords
Funding Information
- The Cyprus Institute of Neurology and Genetics
This publication has 28 references indexed in Scilit:
- Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosisScientific Reports, 2023
- Classification Criteria and Clinical Practice Guidelines for Rheumatic Diseases2021
- Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot StudyGenetic Testing and Molecular Biomarkers, 2020
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusArthritis & Rheumatology, 2019
- 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient CohortsArthritis & Rheumatology, 2016
- Genetics, Epigenetics, and Genomics of Systemic SclerosisRheumatic Disease Clinics of North America, 2015
- Update on biomarkers in systemic sclerosis: tools for diagnosis and treatmentSeminars in Immunopathology, 2015
- Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based ProteomicsMolecular & Cellular Proteomics, 2014
- Heart-specific isoform of tropomyosin4 is essential for heartbeat in zebrafish embryosCardiovascular Research, 2008
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001